Clinical Trials Browser

Phase 1 × Suspended × Solid Tumors × Clear all

NCT00591682 2008-03-26

MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Phase 1 Suspended

Other solid neoplasm

Solid Tumors